On June 5, 2023, Crystal Mischley was diagnosed with 3B Bulky Classical Hodgkin's Lymphoma For more than a year, Crystal Mischley had been struggling with a series of troubling symptoms. It all ...

Discover how innovative lymphoma treatments are transforming patient outcomes, from targeted therapies to immunotherapy ...

Takeda's Adcetris has become the first drug recommended for routine NHS use as a treatment for previously untreated ...

From today, adults with advanced Hodgkin lymphoma have access to a new treatment, after we recommended brentuximab vedotin (brand name Adcetris) in combination with other therapies for routine NHS use ...

Treatment consisted of 4-6 cycles of dose-dense intensive chemotherapy incorporating hyperfractionated cyclophosphamide/ifosfamide, high-dose cytarabine and methotrexate, doxorubicin, etoposide, ...

NICE recommended Pfizer's Adcetris for NHS use in advanced Hodgkin lymphoma, citing strong trial data and a new discount agreement with Takeda.

Patients on Adcetris and chemo had better progression-free and overall survival after six years of follow-up compared to those on chemo only.

It is estimated that about 800 people with Hodgkin lymphoma could benefit from the decision by the National Institute for ...

DelveInsight’s Non-Hodgkin Lymphoma pipeline report depicts a robust space with 200+ Non-Hodgkin Lymphoma companies working ...

On June 5, 2023, Crystal Mischley was diagnosed with 3B Bulky Classical Hodgkin's Lymphoma Prince William sends strong message from tank near Russian border A Critical Metal Jumps 500% After Xi ...